Analogous in vivo assays confirmed significant tumor growth reduction when the cells were depleted in Maoa or Hrh1 expression and in mice treated with rapamycin, relative to pLKO‐transduction and equivalent administration of rapamycin (Appendix Fig S10B). This evidence concerns the gene HRH1 and neoplasm.